click below
click below
Normal Size Small Size show me how
ch. 51
pharmacology
| Term | Definition |
|---|---|
| Absorption | process of how a drug moves into the systemic circulation |
| adverse effects | |
| anaphylactic shock | |
| bioavailability | |
| bioequivalent | |
| blood-brain barrier | causes some drugs to be poorly distributed to the CNS because they must pass through it, protects the brain from many toxic substances, also helps to keep needed antibiotics from being able to treat CNS infections |
| brand name | |
| complementary and alternative medicine (CAM) | |
| computerized physician order entry (CPOE) | |
| contraindicated | |
| controlled substances | drugs classified under the federal controlled substances act as having a potential for addiction or abuse |
| controlled substances act (CSA) | 1970 federal US drug policy regulating manufacture, importation, possession, use, & distribution of certain substances (controlled substances) |
| distribution | |
| drugs | comes from natural sources, including plants, animals, and minerals, and others are artificially created. |
| drug dependency | |
| drug enforcement administration (DEA) | agency of federal government responsible for drug control enforcement. |
| drug intolerance | cannot tolerate the medication anymore so you stop |
| drug tolerance | used to the body and need more |
| enzyme induction | |
| execration | |
| generic name | |
| habituation | dependence on a drug |
| herbal supplement | |
| idiosyncratic | |
| inscription | |
| lethal | |
| medications | |
| metabolism | also called biotransformation, most occurs in liver, using same biochemical reactions and pathways affect minerals, nutrients, and vitamins. |
| over the counter (OTC) | |
| pharmacists | |
| pharmacokinetics | study of drug movement through-out the body |
| pharmacology | |
| polypharmacy | |
| prophylactically | |
| propriety name | |
| side effects | |
| signa (sig.) | |
| subscription | |
| superscription | |
| superscription | |
| synthetic | |
| toxic | |
| pharmacology | |
| capitation | patients are assigned a per-member, per-month payment based on age, race, sex, lifestyle, medical history, & benefit design. |
| managed care | plans that provide health care in return for preset scheduled payments and coordinated care through a defined network of providers and hospitals |
| PPO | an insured person does not need a PCP and go directly to a specialist without referrals |
| HMO | a planned requires referrals to specialists, as well as precertification and preauthorization for hospital, admissions, outpatient procedures, and treatment |
| SCHEDULE I | includes substances that have a high potential for abuse and currently no approved medical use in United States |
| SCHEDULE II | Substances that have a high potential for abuse, are considered dangerous, and can lead to phycological and physical dependence |
| SCHEDULE III | Includes substances that have a moderate to low potential for physical and psychological dependence (can refill) |
| SCHEDULE V | Substances that contain limited quantities of some narcotics, usually for antidiarrheal, antitussive, and analgesic purposes (can refill) |
| SCHEDULE IV | Includes substances that have a low potential for abuse and dependance (can refill) |
| ID | intradermally |
| IM | intramuscularly |
| INJ | injection |
| IV | intravenously |
| PO | BY MOUTH |
| PR | |
| SUBCUT/SUBQ | |
| Anaphylactic shock | life-threatening adverse reaction, usually to a drug, a certain food, or an insect bite or sting |
| Nsaids | nonsteroidal anti-flammatory drug |
| CNS | Central Nervous System |